Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter phase 3 study of inhaled Utilin versus GINA-based therapy in mild to moderate asthma
ChiCTR-TRC-10000765Phase 3Completed
- Sponsor
- Health Commission of Guangxi Zhuang Autonomous Region
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Utilin, salmeterol + fluticasone, saline and salbutamol in asthma (3 arms), sponsored by Health Commission of Guangxi Zhuang Autonomous Region. Primary endpoint: PD20-FEV1. Started May 2000; status: completed.
02
Drugs
Utilinsalmeterol + fluticasonesalinesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-TRC-10000765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000765.